JPMorgan Nasdaq Equity Premium Income ETF vs UiPath Inc — how do they compare? JPMorgan Nasdaq Equity Premium Income ETF trades at $61.21 (market cap $44.49B), while UiPath Inc trades at $13.33 (market cap $6.91B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 6.4× UiPath Inc's market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, UiPath Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Nasdaq Equity Premium Income ETF for 65 Days and UiPath Inc for 139 Days on average.
| JEPQ | PATH | |
|---|---|---|
Market Cap | $44.49B | $6.91B |
Volume | 5,681,789 | 34,321,250 |
Sector | Income / Options Overlay | Technology |
52-Week High | $61.46 | $19.29 |
52-Week Low | $53.77 | $9.38 |
Typical Hold Time | 65 Days | 139 Days |
Enterprise Value | — | $5.70B |
Signals from Pluang's Aura AI — not financial advice
JEPQ trades at $61.27 with minimal daily movement (+0.03%), showing technical bullish momentum with strong moving average support. The ETF maintains an estimated 11% annualized yield through its covered call strategy on Nasdaq-100 stocks, though recent oscillators suggest potential near-term consolidation. Recent news highlights JEPQ's popularity among income-focused investors seeking monthly distributions from tech exposure.
JEPQ offers high income generation but faces trade-offs between yield and capital appreciation. The fund's performance depends heavily on market volatility for option premium income, with limited upside during strong bull markets. Key risks include concentrated tech exposure and variable dividend payments that fluctuate with market conditions.
UiPath (PATH) trades at $13.07, down 0.23% on the day, amid a bearish technical signal and mixed earnings history. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while net income is expected to turn positive. Recent news highlights AI partnerships and product innovations, but the stock faces headwinds from cautious analyst sentiment and technical resistance.
The outlook for PATH is cautiously optimistic, with strong revenue growth and a path to profitability offering upside potential, but risks include execution challenges and competitive pressures. The consensus price target of $15.13 suggests moderate upside from current levels, though investor sentiment remains divided.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →